Literature DB >> 12454564

5HT2A and 5HT2C receptor polymorphisms and predicting clinical response to olanzapine in schizophrenia.

Vicki L Ellingrod, Paul J Perry, Brian C Lund, Kristy Bever-Stille, Frank Fleming, Timothy L Holman, Del Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12454564     DOI： 10.1097/00004714-200212000-00014

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  6 in total

Review 1.  Pharmacogenetics and psychiatry.

Authors:  Amlan Basu; Eva Tsapakis; Kathy Aitchison
Journal:  Curr Psychiatry Rep       Date:  2004-04       Impact factor: 5.285

Review 2.  Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.

Authors:  Jian-Ping Zhang; Anil K Malhotra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-01       Impact factor: 4.481

Review 3.  Pharmacogenetics of antipsychotics.

Authors:  Eva J Brandl; James L Kennedy; Daniel J Müller
Journal:  Can J Psychiatry       Date:  2014-02       Impact factor: 4.356

Review 4.  The impact of atypical antipsychotic use on obstructive sleep apnea: a pilot study and literature review.

Authors:  Afshin Shirani; Sergio Paradiso; Mark Eric Dyken
Journal:  Sleep Med       Date:  2011-06       Impact factor: 3.492

5.  Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas.

Authors:  M M Doat-Meyerhoefer; R Hard; J C Winter; R A Rabin
Journal:  Pharmacol Biochem Behav       Date:  2005-08       Impact factor: 3.533

Review 6.  Intramuscular olanzapine: a review of its use in the management of acute agitation.

Authors:  Antona J Wagstaff; Jane Easton; Lesley J Scott
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.